Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating activities
Net earnings (loss)	$ 510	$ 512
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
Other charges (gains), net of amounts used	(13)	(8)
Depreciation, amortization and accretion	236	231
Deferred income taxes, net	(96)	7
(Gain) loss on disposition of businesses and assets, net	2	0
Refinancing expense	0	3
Other, net	85	49
Operating cash provided by (used in) discontinued operations	0	(9)
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net	(62)	(175)
Inventories	1	(167)
Other assets	15	3
Trade payables - third party and affiliates	58	77
Other liabilities	(75)	(42)
Net cash provided by (used in) operating activities	661	481
Investing activities
Capital expenditures on property, plant and equipment	(270)	(241)
Acquisitions, net of cash acquired	(23)	(8)
Proceeds from sale of businesses and assets, net	1	6
Deferred proceeds from Kelsterbach plant relocation	0	158
Capital expenditures related to Kelsterbach plant relocation	(43)	(174)
Other, net	(62)	(37)
Net cash provided by (used in) investing activities	(397)	(296)
Financing activities
Short-term borrowings (repayments), net	(7)	(20)
Proceeds from long-term debt	0	411
Repayments of long-term debt	(32)	(562)
Refinancing costs	0	(8)
Purchases of treasury stock, including related fees	(37)	(28)
Stock option exercises	58	19
Series A common stock dividends	(31)	(25)
Preferred stock dividends	0	0
Other, net	28	(11)
Net cash provided by (used in) financing activities	(21)	(224)
Exchange rate effects on cash and cash equivalents	3	3
Net increase (decrease) in cash and cash equivalents	246	(36)
Cash and cash equivalents as of beginning of period	682	740
Cash and cash equivalents as of end of period	$ 928	$ 704